資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/30970
|
| 標題: | Chitosan promotes immune responses, ameliorates glutamic oxaloacetic transaminase and glutamic pyruvic transaminase, but enhances lactate dehydrogenase levels in normal mice in vivo |
| 作者: | Yeh, Ming-Yang
Shih, Yung-Luen
Chung, Hsueh-Yu
Chou, Jason
Lu, Hsu-Feng
Liu, Chia-Hui
Liu, Jia-You
Huang, Wen-Wen
Peng, Shu-Fen
Wu, Lung-Yuan
Chung, Jing-Gung |
| 貢獻者: | Cheng Hsin Gen Hosp, Off Director
Fu Jen Catholic Univ, Dept Sch Med
Shin Kong Wu Ho Su Mem Hosp, Dept Pathol & Lab Med
Taipei Med Univ, Sch Med Lab Sci & Biotechnol
Jen Teh Jr Coll Med Nursing & Management
Cheng Hsin Gen Hosp, Dept Anat
Cheng Hsin Gen Hosp, Dept Clin Pathol
Chia Nan Univ Pharm & Sci, Ctr Gen Educ
China Med Univ, Dept Biol Sci & Technol
I Shou Univ, Sch Chinese Med Post Baccalaureate, Yanchao Campus,8 Yida Rd
Asia Univ, Dept Biotechnol |
| 關鍵字: | chitosan
immune responses
glutamic oxaloacetic transaminase
glutamic pyruvic transaminase
lactate dehydrogenase |
| 日期: | 2016-04 |
| 上傳時間: | 2018-01-18 11:38:56 (UTC+8) |
| 出版者: | Spandidos Publ Ltd |
| 摘要: | Chitosan, a naturally derived polymer, has been shown to possess antimicrobial and anti-inflammatory properties; however, little is known about the effect of chitosan on the immune responses and glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and lactate dehydrogenase (LDH) activities in normal mice. The aim of the present study was to investigate whether chitosan has an effect on the immune responses and GOT, GPT and LDH activities in mice in vivo. BALB/c mice were divided into four groups. The negative control group was treated with a normal diet; the positive control group was treated with a normal diet plus orally administered acetic acid and two treatment groups were treated with a normal diet plus orally administered chitosan in acetic acid at doses of 5 and 20 mg/kg, respectively, every other day for 24 days. Mice were weighed during the treatment, and following the treatment, blood was collected, and liver and spleen samples were isolated and weighted. The blood samples were used for measurement of white blood cell markers, and the spleen samples were used for analysis of phagocytosis, natural killer (NK) cell activity and cell proliferation using flow cytometry. The results indicated that chitosan did not markedly affect the body, liver and spleen weights at either dose. Chitosan increased the percentages of CD3 (T-cell marker), CD19 (B-cell marker), CD11b (monocytes) and Mac-3 (macrophages) when compared with the control group. However, chitosan did not affect the phagocytic activity of macrophages in peripheral blood mononuclear cells, although it decreased it in the peritoneal cavity. Treatment with 20 mg/kg chitosan led to a reduction in the cytotoxic activity of NK cells at an effector to target ratio of 25: 1. Chitosan did not significantly promote B-cell proliferation in lipopolysaccharide-pretreated cells, but significantly decreased T-cell proliferation in concanavalin A-pretreated cells, and decreased the activity of GOT and GPT compared with that in the acetic acid-treated group,. In addition, it significantly increased LDH activity, to a level similar to that in normal mice, indicating that chitosan can protect against liver injury. |
| 關聯: | Experimental and Therapeutic Medicine, v.11 n.4, pp.1300-1306 |
| 顯示於類別: | [文化事業發展系] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| 30970.pdf | | 567Kb | Adobe PDF | 395 | 檢視/開啟 | | index.html | | 0Kb | HTML | 2039 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
